Open Access System for Information Sharing

Login Library

 

Article
Cited 7 time in webofscience Cited 6 time in scopus
Metadata Downloads
Full metadata record
Files in This Item:
DC FieldValueLanguage
dc.contributor.authorMoon, HGko
dc.contributor.authorKim, YSko
dc.contributor.authorChoi, JPko
dc.contributor.authorChoi, DSko
dc.contributor.authorYoon, CMko
dc.contributor.authorJeon, SGko
dc.contributor.authorGho, YSko
dc.contributor.authorKim, YKko
dc.date.available2016-04-01T02:56:08Z-
dc.date.created2013-11-01-
dc.date.issued2010-01-
dc.identifier.citationEXPERIMENTAL AND MOLECULAR MEDICINE, v.42, no.1, pp.47 - 60-
dc.identifier.issn1226-3613-
dc.identifier.other2010-OAK-0000021107-
dc.identifier.urihttp://oasis.postech.ac.kr/handle/2014.oak/26009-
dc.description.abstractTheophylline is commonly used to treat severe asthma and chronic obstructive pulmonary disease (COPD) characterized by non-eosinophilic inflammation. Acetyl salicylic acid (ASA) is one of the most widely used medications worldwide, but up to 20% of patients with asthma experience aggravated respiratory symptoms after taking ASA. Here we evaluated the adverse effect of ASA on the therapeutic effect of theophylline in mice with non-eosinophilic asthma. A non-eosinophilic asthma mouse model was induced by airway sensitization with lipopolysaccharide-containing allergen and then challenged with allergen alone. Therapeutic intervention was performed during allergen challenge. Theophylline inhibited lung inflammation partly induced by TO immune response. ASA attenuated the beneficial effects of theophylline. However, co-administration of the ASA metabolite salicylic acid (SA) showed no attenuating effect on theophylline treatment. The therapeutic effect of theophylline was associated with increase in cAMP levels, which was blocked by co-treatment of theophylline and ASA. ASA co-treatment also attenuated the anti-inflammatory effects of a specific phosphodiesterase 4 inhibitor. These results demonstrate that ASA reverses anti-inflammatory effects of theophylline, and that ASA exerts its adverse effects through the inhibition of cAMP production. Our data suggest that ASA reverses lung inflammation in patients taking theophylline, although clinical evidence will be needed.-
dc.description.statementofresponsibilityX-
dc.languageEnglish-
dc.publisherNature Publishing Group-
dc.titleAspirin attenuates the anti-inflammatory effects of theophylline via inhibition of cAMP production in mice with non-eosinophilic asthma-
dc.typeArticle-
dc.contributor.college생명과학과-
dc.identifier.doi10.3858/EMM.2010.42.1.005-
dc.author.googleMoon, HG-
dc.author.googleKim, YS-
dc.author.googleChoi, JP-
dc.author.googleChoi, DS-
dc.author.googleYoon, CM-
dc.author.googleJeon, SG-
dc.author.googleGho, YS-
dc.author.googleKim, YK-
dc.relation.volume42-
dc.relation.issue1-
dc.relation.startpage47-
dc.relation.lastpage60-
dc.contributor.id10138843-
dc.publisher.locationUK-
dc.relation.journalEXPERIMENTAL AND MOLECULAR MEDICINE-
dc.relation.indexSCI급, SCOPUS 등재논문-
dc.relation.sciSCI-
dc.collections.nameJournal Papers-
dc.type.rimsART-
dc.contributor.localauthorGho, YS-
dc.contributor.localauthorKim, YK-
dc.contributor.nonIdAuthorMoon, HG-
dc.contributor.nonIdAuthorKim, YS-
dc.contributor.nonIdAuthorChoi, JP-
dc.contributor.nonIdAuthorChoi, DS-
dc.contributor.nonIdAuthorYoon, CM-
dc.contributor.nonIdAuthorJeon, SG-
dc.identifier.wosid000274293800006-
dc.date.tcdate2019-02-01-
dc.citation.endPage60-
dc.citation.number1-
dc.citation.startPage47-
dc.citation.titleEXPERIMENTAL AND MOLECULAR MEDICINE-
dc.citation.volume42-
dc.identifier.localId0000021107-
dc.identifier.localId0000021167-
dc.identifier.scopusid2-s2.0-76749122477-
dc.description.journalClass1-
dc.description.wostc7-
dc.description.scptc6*
dc.date.scptcdate2018-05-121*

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher

 GHO, YONG SONG
Dept of Life Sciences
Read more

Views & Downloads

Browse